Author:
Huscroft Ian T.,Carlson Emma J.,Chicchi Gary G.,Kurtz Marc M.,London Clare,Raubo Piotr,Wheeldon Alan,Kulagowski Janusz J.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference14 articles.
1. Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist
2. Aprepitant
3. A Potent Nonpeptide Antagonist of the Substance P (NK
1
) Receptor
4. Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements
5. Thomson, C. G.; Carlson, E.; Chicchi, G. G.; Kulagowski, J. J.; Kurtz, M. M.; Swain, C. J.; Tsao, K. C.; Wheeldon, A. Bioorg. Med. Chem. Lett., in press.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献